Hudock Inc. Invests $229,000 in iShares Biotechnology ETF (NASDAQ:IBB)

Hudock Inc. bought a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 1,734 shares of the financial services provider’s stock, valued at approximately $229,000.

Several other hedge funds and other institutional investors have also modified their holdings of IBB. BNP Paribas Financial Markets boosted its holdings in shares of iShares Biotechnology ETF by 29.3% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after buying an additional 538,899 shares during the period. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in shares of iShares Biotechnology ETF by 32.9% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares during the period. Aprio Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at about $18,476,000. DRW Securities LLC acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $5,990,000. Finally, Erste Asset Management GmbH acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $5,678,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 0.9 %

NASDAQ IBB opened at $135.47 on Thursday. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57. The company has a 50-day simple moving average of $135.88 and a 200-day simple moving average of $141.13.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.